Gaps In Spiked Supplement Net Could Shrink With Non-Targeted Screening
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to deploy testing technology that casts a wider net than its existing targeted adulterant tests, intending to catch product that may be tainted with as-yet-unknown adulterants.
You may also be interested in...
Spiked “Supplements” For Diabetes, Pain On The Rise
FDA is seeing supplements spiked with Rx ingredients indicated for pain management and diabetes treatment, and needs industry help identifying violators, CFSAN head Michael Landa says.
FDA Action On Sexual Supplements Should Spur Better Self-Policing – UNPA
The proliferation of erectile dysfunction "dietary supplements" adulterated with prescription drugs should lead the supplement industry to sharpen its capabilities to keep these illegal products off the market, United Natural Products Alliance President Loren Israelsen says
US Market For OTC COVID-19 Tests Transitions From Unmet Demand To Multiple Choices
Abbott’s’s distribution of its BinaxNOW COVID-19 Ag Self Test to US retailers increases to three the number of OTC tests for the virus that CVS offers, along with Ellume’s and Labcorp’s test kits also available under EUAs granted by FDA.